Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.10p +0.57% 17.50p 17.20p 17.80p 17.50p 17.40p 17.40p 21,124 12:47:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.0 -3.3 - 16.32

Evgen Pharma Share Discussion Threads

Showing 1026 to 1049 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
06/7/2018
21:13
A new Evgen article; Scientists synthesize new compound with anticarcinogenic properties hTTps://www.news-medical.net/news/20180705/Scientists-synthesize-new-compound-with-anticarcinogenic-properties.aspx
pdt
02/7/2018
10:29
Hardman issued a new updated report at the end of last week (June 29th) which is worth a read http://hardmanandco.com/docs/default-source/company-docs/evgen-pharma-documents/29.06.18-2018-a-pivotal-year.pdf?dm_i=49CL,AURS,ZPOPX,16WMG,1
timbo003
02/7/2018
09:07
All gone quiet here. But something doesn't add up recently. Only sells going through but share price static and not dropping. Any idea why.
wins73
20/6/2018
20:07
Possible, but I see a cashed strapped company on the back heel. Hence a fund raising and dilution shortly.
l0ngterm
20/6/2018
20:05
L0ngterm I can see Pfizer buying EVG if the phase II cancer results are good as the drug is being targeted at patients who have failed Ibrance. In fact they might not wait that long.... It will enable them to give the whole treatment paradigm to the oncologists which Pharmas like to do. They effectively like to 'own' a disease. Nobby
nobbygnome
20/6/2018
19:53
The problem I have here is what the company will have to raise via a funding. It's Great the cancer trials hitting the mark, but the leverage for any negotiations is the stroke results, as that's what can be expedited with the fda for generating a return for a partner. Otherwise it's dilution and negotiating, a deal which need cash and also requires covering x years, before a return.
l0ngterm
20/6/2018
12:24
There was an investor presentation yesterday which may explain the rise today?
pdt
17/6/2018
15:42
I totally agree about the salvage setting.The ten thousand dollar question is therefore ,"how do we get this across to prospective investors" I have a feeling that Nobby was anticipating this and that was why he kept emphasizing that anything in excess of 20 per cent would be a good result.
teddy boy1
15/6/2018
11:40
Found that genuinely interesting and reassuring after Monday's market reaction. The "salvage setting" explains a lot.
jimbobtechstock
15/6/2018
11:14
Dr Stephen Franklin discusses their interim update on the STEM clinical trial in this DT interview: INTERVIEW - http://bit.ly/2JKoF7i Q&A - http://bit.ly/2JNYPiM
astonedt
15/6/2018
07:37
>> teddy There is a long way to go before the drug is on the market but there is no doubt the current market cap doesn't reflect the potential. After all we have 2 trials in different indications coming out before the end of the year. We only need one of them to be positive and we will be off to the races. I am pretty certain the breast cancer indication will be positive and there will be a lot more open label data on top of the trial data by then. The stroke indication is more difficult to assess IMHO but if it does produce a positive result, it will have a big impact on the price because it addresses an unmet need. So plenty to be optimistic about here and I am more than happy to hold for the end of the year. I have to admit to selling net 25% of my holding above 25p on Monday but will be looking to add in a big way ahead of the results at the end of the year. GLA Nobby
nobbygnome
14/6/2018
21:15
I had a look at the interview and its just a shame that more people haven,t viewed it as it brings home to you just what a good result it is so far, given the parameters. Won,t it be nice if this is carried forward to the end of the year,and that eventually it will become part of the "normal " treatment for advanced cancer sufferers . Think of the hope that it give to many compared with the miserable options that these people are confronted with at present! This treatment is looking very promising and eventually could provide hope for many. Fingers crossed that everything remains on target!
teddy boy1
14/6/2018
13:56
Just had a listen to the Directors Talk interview about the interim trial results. It was good to hear him upbeat on the results. Worth a listen. It put the results in context as a "salvage" operation and setting the bar high. It has enabled them to get data in respect of which hormone treatment will work best with SFX-01. The latest presentation suggests Fulvestrant is the one they will combine with. Therefore the headline results for that cohort are likely to be better than for the trial overall. In addition I assume the next phase II will be second line use of Fulvestrant plus SFX-01 as a new hormone treatment rather than a follow on of a failing hormone treatment giving even better chance of success. They seem to have the next 4 years ahead planned out already, a phase II followed by a phase IIb/III. And are clear on the commercial opportunity ahead. If they have this much detail on a development pathway now and the plan is to partner I do wonder if they are already talking to potential licensees and this is what they have been advised to do? Interesting times.
pdt
14/6/2018
13:10
TIMBO You seem to be held in quite high esteem here? Two questions if I may ? (a) What did YOU think of the trial update and longer term prospects? (b) How come more investors are not buying into the story? At what price do you think they will be tempted to do so? I appreciate that this will be just an opinion ,rather than advice .
teddy boy1
14/6/2018
10:32
I think its more a question of patience rather than fighting. Like Harbourside I have my position to hold for 12 months by which time we will have two phase II results and probably a licence deal. I like the science, the results so far and the risk/reward ratio. It is also encouraging that posters like NG and Timbo are interested.
pdt
14/6/2018
10:13
Yet another tree shake this morning.On the basis of todays very thin trading was this justified? Absolutely not! I will say it one more time (at least) -this share is being well and truly "worked" and until such times as buyers return in force these people have the upper hand! How low can it go? As low as they want to take it ! UNLESS - we stand up and fight back! This is becoming almost too farcical for words _ how can a company with such a promising update be marked down so savagely? Its just as I said yesterday - if there is a TINY shadow of doubt about a small companys future or results(especially one where the shares are very tightly held) these people will work on this by stepping down the price so that some investors will read something into this (when there is nothing untoward) and sell their shares and this in turn sets of a series of buys- this can then be repeated again and again, almost on a daily basis if they so desire ! The result- we end up with a ropey share price which produces a valuation which bears no relationship to the worth of that company! Are we just going to stand back and let it happen? ,content in the knowledge that once in a while we will be allowed one "good " day when they dispose of their accumulated shares, by stepping up the price to try and fool us that something good is afoot and all of a sudden after days of hardly any buying, people investors pile in again and try to fool themselves into coming up with "reasons" for the rise. LETS FIGHT, FIGHT AND FIGHT !
teddy boy1
14/6/2018
08:02
New Hardman Research note here: http://www.hardmanandco.com/docs/default-source/company-docs/evgen-pharma-documents/13.06.18-encouraging-interim-data-from-the-stem-trial.pdf?dm_i=49CL,AD0Q,ZPOPX,14VT4,1
timbo003
14/6/2018
08:00
New Interview here: https://www.directorstalk.net/interview-evgen-pharma-stem-trial-positive-early-signs/
timbo003
13/6/2018
18:42
Thanks TB1. Point is there were a lot of investors jumped in and out of IMM for a quick 10 pct and ended up, when the story looked good, jumping back in for many multiples that they shipped out for that quick profit and unfortunately got caught/locked in at the higher price (or like me didn’t have the conviction to take a larger position at a cheaper price and chased the share price up). If they had had the patience and conviction (which equated to about 18 months from the mid 20’s up) to hold and not get tempted by the quick 10 per cent gain then even with a bad result they still would have fared ok, not the mega bagging predicted but ok. EVG is a different animal to IMM science wise as NG has pointed out but I can see the same thing happening in 6 to 18 months here so certainly will not be tempted by daily movements, I have my position and am happy to let the story unfold, you live and learn. GLA holders.
harbourside
13/6/2018
18:33
Ok, I'm not bothered about daily movements here either. The way I see it, if the phase 3 goes well, they will likely end up becoming a manufacturer of their patented product, which will see the company worth substantially more than today. Clearly the word is getting out in many publications, about the product and the company. My only question... Is it worth investing (and adding) at todays level, for the future success in 3yrs or even 5+yrs?
apfindley
13/6/2018
17:08
HARBOURSIDE -A good sensible post. I agree that a lot of patience will be required on this one so probably not much sense in getting hung up on daily movements of the share price!
teddy boy1
13/6/2018
15:44
Have held EVGEN for a while now, little price movement initially, then a placing so a bit of a drop but again no movement for months, with such a small free float a few trades here and there do move the price. With the interim data due the price moved quickly up (which was probably due to some ramping) once achieved profit taken and moved back down but to a higher low. IMO this is promising company, the management seem committed and believe in their research (to the point that they would sell their house and invest in the company). This will move up and down on sentiment and expectation probably until the results at year end, there is always going to be investors who jump on board for the 10 - 15 per cent ride then jump off again, others will want to stay invested but don’t like to see an initial 10 per cent profit walked back down so will sell and hope for a drop to get back in, rinse and repeat, until it passes that point when long term investors buy and hold (I don’t like comparing this to IMM but I was in there when it was a 25p share to stick in the bottom drawer for a year, the price shot up on days and walked back down several times before it went up and stayed there until the bad results, if you had bought in at 25p way back when and got out post results chances are you would still have made money, I didn’t buy enough at 25p on that one but won’t make that mistake with EVG). Good results, looking good for year end so no reason apart from trading and profit taking, for the drop. Also good to see NG, one of the few who called the science part of IMM right, posting optimistically about EVG, hopefully he is just as correct about EVG’s science as he was about IMM. GLA holders.
harbourside
13/6/2018
15:18
I have checked in with some of my City mates and the mood there is one of amazement that the Engen share price has not risen substancially. A 20 per cent response rate was what was what was aimed for and this was achieved plus a bit more (2 of the patients had their tumour halted for 18 weeks) No one will actually admit to the share being "got at" but I have no doubt myself that this is what has been happening. ! How low can they take it? That is the leading question!, but rest assured : when these horrible people have achieved what they set out to do and made themselves a lot of money the price will be allowed to rise again. Then what? Probably the next "cycle" will begin all over again!
teddy boy1
13/6/2018
12:25
Have just checked on todays trading and see that BUYS outweigh sells by half as much again and yet the share price is way down on the day.! How can this be right (morally) Can someone please explain the logic behind all this ?( apart from share price manipulation of the first degree)
teddy boy1
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180716 12:10:46